US Physicians Purchasing Group

Belkins
U.S. Physician’s Purchasing Group (USPPG), formed in 2003, is a group purchasing organization whose sole mission is to provide physicians and their medical practices access to competitive pricing by leveraging the power of large group procurement. USPPG is contracted with GlaxoSmithKline (GSK), so its members can always purchase GSK vaccines at preferred pricing. This agreement gives every USPPG member the opportunity for significant savings by effectively managing GSK vaccine costs.

Related News

TSCAN AND NOVARTIS PARTNER TO DEVELOP CANCER THERAPIES

Pharmaceutical Technology | April 16, 2020

news image

Biopharmaceutical firm TScan Therapeutics has signed an agreement with Novartis to discover and develop therapies for the treatment of cancer. The companies aim to work on TCR-engineered T-cell therapies for solid tumours. TScan’s platform will identify cancer antigens that could be targeted by TCR-based treatments. As part of the deal, TScan will find and characterise TCRs while Novartis will hold an option to licence and develop TCRs for up to three new targets. Furthermore, Novartis wil...

Read More

PHARMACY MARKET

MALLAX ACQUIRES SANA PHARMA MEDICAL, ESTABLISHING A NEW NORDIC PHARMACEUTICAL PLATFORM

Mallax | July 05, 2021

news image

Mallax Pharmaceuticals AB has acquired Sana Pharma Medical AS, forming a new Nordic pharmaceutical platform. SPM, founded in Norway in 2014, is a rapidly growing OTC company with complete pharmaceutical infrastructure and Nordic distribution coverage. With the well-established brands such as Lunixen and Sedix and additional products based on the chemical melatonin, the Company has a leading position in the fast-growing sleep and anxiety sector. SPM is a well-resourced platform wit...

Read More

US PHARMACEUTICAL SUPPLY CHAIN UNPREPARED FOR COVID-19

Healio | April 27, 2020

news image

In this guest editorial, Pinar Keskinocak, PhD, director of the Center for Health and Humanitarian Systems and a professor in the H. Milton Stewart School of Industrial and Systems Engineering at Georgia Institute of Technology, and Evren Ozkaya, PhD, founder and CEO of the management consulting and digital solutions firm Supply Chain Wizard, discuss how pandemics create chaos in global medical supply chains and ways to alleviate this burden. Pandemics encumber the supply of medications needed t...

Read More

PHARMACY MARKET

FUSION PHARMACEUTICALS AND TRIUMF ANNOUNCE EXPANDED R&D COLLABORATION FOR ACTINIUM SUPPLY PRODUCTION

Fusion Pharmaceuticals Inc. | August 13, 2021

news image

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, and TRIUMF, Canada's particle accelerator centre, today announced that the companies have entered into the next phase of their collaboration agreement for the development, production, and supply of actinium-225. Fusion will provide to TRIUMF funding to further develop technology to produce actinium-225 and in return Fusion will have ...

Read More
news image

TSCAN AND NOVARTIS PARTNER TO DEVELOP CANCER THERAPIES

Pharmaceutical Technology | April 16, 2020

Biopharmaceutical firm TScan Therapeutics has signed an agreement with Novartis to discover and develop therapies for the treatment of cancer. The companies aim to work on TCR-engineered T-cell therapies for solid tumours. TScan’s platform will identify cancer antigens that could be targeted by TCR-based treatments. As part of the deal, TScan will find and characterise TCRs while Novartis will hold an option to licence and develop TCRs for up to three new targets. Furthermore, Novartis wil...

Read More
news image

PHARMACY MARKET

MALLAX ACQUIRES SANA PHARMA MEDICAL, ESTABLISHING A NEW NORDIC PHARMACEUTICAL PLATFORM

Mallax | July 05, 2021

Mallax Pharmaceuticals AB has acquired Sana Pharma Medical AS, forming a new Nordic pharmaceutical platform. SPM, founded in Norway in 2014, is a rapidly growing OTC company with complete pharmaceutical infrastructure and Nordic distribution coverage. With the well-established brands such as Lunixen and Sedix and additional products based on the chemical melatonin, the Company has a leading position in the fast-growing sleep and anxiety sector. SPM is a well-resourced platform wit...

Read More
news image

US PHARMACEUTICAL SUPPLY CHAIN UNPREPARED FOR COVID-19

Healio | April 27, 2020

In this guest editorial, Pinar Keskinocak, PhD, director of the Center for Health and Humanitarian Systems and a professor in the H. Milton Stewart School of Industrial and Systems Engineering at Georgia Institute of Technology, and Evren Ozkaya, PhD, founder and CEO of the management consulting and digital solutions firm Supply Chain Wizard, discuss how pandemics create chaos in global medical supply chains and ways to alleviate this burden. Pandemics encumber the supply of medications needed t...

Read More
news image

PHARMACY MARKET

FUSION PHARMACEUTICALS AND TRIUMF ANNOUNCE EXPANDED R&D COLLABORATION FOR ACTINIUM SUPPLY PRODUCTION

Fusion Pharmaceuticals Inc. | August 13, 2021

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, and TRIUMF, Canada's particle accelerator centre, today announced that the companies have entered into the next phase of their collaboration agreement for the development, production, and supply of actinium-225. Fusion will provide to TRIUMF funding to further develop technology to produce actinium-225 and in return Fusion will have ...

Read More